Mankind Pharma Limited — Important, 14-05-2025: General Updates

Mankind Pharma’s subsidiary Bharat Serums and Vaccines faces a ₹76.30 Cr additional tax demand linked to transfer pricing and intangible asset depreciation. BSV disputes the claim, expecting no significant financial or operational impact. The company plans to appeal and aims to adjust part of the demand using prepaid tax credits from a prior merger.